STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more
GIST
Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us.
Moreover, the official mascots succeed in spotting various varmints — foxes and possums, to be specific, but thankfully, no vultures. As for us, we are heating our spiffy new replacement kettle for another cuppa stimulation.
Our choice today is old-fashioned green teas. And here is a helpful tip — a teaspoon of honey enhances the flavors splendidly.
Of course, you are invited to join us. For the full experience, we are now hawking replicas —  take a look .
Meanwhile, here are a few items of interest. As always, do keep in touch.
We appreciate feedback, criticism, and tips. … Weight loss drugs will be available to adults 65 and older in Medicare for the first time next month, thanks to a government program that is supposed to be temporary — but it may be difficult to end, STAT explains.
Clinical Editorial
Summary
STAT News published a clinical update in Research Highlights on 16 Jun 2026.
The item focuses on STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more.
Review the original article for the full source wording and details.